BackDeep Medicine Acquisition - Tradeable Rights - Oct 2026 Overview
Deep Medicine Acquisition Corp - Tradeable Rights - Oct 2026

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 Return on Equity

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) has a ROE of -540.28%, below the sector sector average of -5.84%.

Get informed when a big investor buys or sells

+ Follow

ROE

-540.28%

Return on Equity

-540.28%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) FAQ

Deep Medicine Acquisition - Tradeable Rights - Oct 2026 (DMAQR) currently reports a ROE of -540.28%. That is below the sector sector average of -5.84%. Use the charts on this page to explore Deep Medicine Acquisition - Tradeable Rights - Oct 2026's ROE history and peer comparisons.

Deep Medicine Acquisition - Tradeable Rights - Oct 2026's ROE of -540.28% is lower than the its sector sector average of -5.84%. That is roughly 9143.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Deep Medicine Acquisition - Tradeable Rights - Oct 2026's current -540.28% should be judged against industry norms (sector average: -5.84%) and against DMAQR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -540.28%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.84%. From there, open related valuation or income-statement pages for Deep Medicine Acquisition - Tradeable Rights - Oct 2026, and consider following DMAQR for alerts when major investors trade the stock.